Terminal restlessness typically lasts hours to days before death, though the exact duration varies widely from person to person. Research consistently places the onset within the final 48 hours to one week of life, with symptoms often intensifying as death approaches. The range is broad because what clinicians call “terminal restlessness” overlaps with other end-of-life conditions, and some of its triggers are reversible while others are not. Understanding this timeline matters for families and caregivers who are witnessing something deeply distressing and trying to make sense of what comes next.
What Terminal Restlessness Looks Like
Terminal restlessness is an umbrella term for a cluster of agitated behaviors that appear near the end of life. It can show up as thrashing or constant movement in bed, involuntary muscle twitches, fidgeting, pulling at bedsheets or clothing, moaning, calling out, or an inability to settle into a comfortable position.1PubMed. Terminal restlessness in the nursing facility: assessment, palliation, and symptom management Some people cycle between periods of agitation and brief stretches of calm. Others remain restless almost continuously once the symptoms begin. The person may not be fully aware of their surroundings, and attempts to communicate or comfort them sometimes seem to make no difference or even increase the distress.
In older adults, particularly those in long-term care, terminal restlessness can be difficult to distinguish from the agitation these same patients showed during earlier infections, pain flares, or bad reactions to medication.1PubMed. Terminal restlessness in the nursing facility: assessment, palliation, and symptom management That overlap is part of what makes it so hard for families to know whether they are watching the final phase of dying or a treatable episode that might pass.
How Common It Is
Estimates of how many dying people experience terminal restlessness range from roughly a quarter to nearly nine in ten, depending on how the condition is defined and measured. One widely cited figure puts it at 25% to 85% of terminally ill patients in the hours or days before death.2PubMed. The impact on the family of terminal restlessness and its management When researchers use the broader category of terminal delirium, which includes both agitated (hyperactive) and quiet (hypoactive) forms, the numbers climb even higher. Studies suggest that 85% to 88% of people experience some form of delirium in the last week to days of life, and nearly all actively dying people will have at least a quiet subtype of delirium in the final hours.3PubMed Central. A Review of Clinical Signs and Symptoms of Imminent End-of-Life in Individuals With Advanced Illness
That enormous spread in the numbers is not sloppy research. It reflects the reality that terminal restlessness sits on a spectrum. A person who plucks at their blankets for a few hours and then settles into unconsciousness is counted differently from someone who is loudly agitated for days. Both fall under the same label.
The Timeline in More Detail
The most direct evidence about when restlessness peaks comes from studies tracking symptoms in the final hours. Research on cancer patients found that restlessness and agitation increased significantly in prevalence during the last 48 hours of life, alongside other late signs like noisy breathing, sweating, and declining consciousness.4Journal of Hospice and Palliative Care. Symptom Prevalence During Terminal Cancer Patients’ Last 48 Hours of Life That pattern of escalation is typical: restlessness tends to appear or worsen as the body’s systems begin to shut down, and it often intensifies rather than plateaus.
For some people, restlessness appears a full week or more before death, sometimes waxing and waning for days before becoming constant. For others, it appears in the final hours and is mercifully brief. When researchers looked specifically at delirium that proved irreversible, meaning the person never regained clarity, those patients lived an average of about 17 days after the onset of delirium. Patients whose delirium was reversible, meaning they had periods of lucidity or the delirium resolved with treatment, survived an average of about 40 days.5PubMed. Reversibility of delirium in terminally ill patients and predictors of mortality Those numbers are averages with wide variation, but the key finding is intuitive: when the restlessness responds to treatment, the person is not necessarily in the final hours. When it does not respond, death tends to be closer.
Why Some Episodes Are Short and Others Last Days
The duration of terminal restlessness depends heavily on what is driving it. Clinicians point to a range of physical triggers: the metabolic chaos of organ failure, medication toxicity, uncontrolled pain, a full bladder or bowel, difficulty breathing, low oxygen levels, and infection.6PubMed. Terminal restlessness as perceived by hospice professionals Some of these causes are fixable, even very late in the dying process. A urinary catheter for a distended bladder, a dose adjustment for a medication causing confusion, or a repositioning to ease breathing can sometimes calm a restless patient within minutes to hours.7PubMed Central. Hospice Clinicians’ Approaches to Terminal Restlessness: A Qualitative Analysis
The trickier reality is that what looks like a straightforward case of terminal restlessness may actually be medication-induced delirium. Opioids, sedatives, and other drugs used for symptom control at the end of life can themselves cause agitation, confusion, and restlessness. Because the clinical picture looks so similar to the restlessness caused by the dying process itself, the two are frequently confused.8PubMed. First do no harm… Terminal restlessness or drug-induced delirium When the agitation is actually drug-induced, adjusting or rotating medications can resolve it. When it stems from irreversible organ failure, it generally continues until the person loses consciousness or dies.
This distinction matters enormously for families watching it unfold. If a loved one becomes agitated shortly after a medication change, it is worth asking the care team whether the medication itself could be contributing. Good palliative care teams routinely work through this checklist, but families sometimes assume that all agitation at the end of life is simply “part of dying” and do not raise the question.
How Terminal Restlessness Is Managed
Management typically starts with identifying and treating any reversible cause. Beyond that, the approaches split into non-drug and drug categories, and most palliative care teams use both simultaneously.
Non-pharmacological approaches include keeping the environment calm and quiet, reducing bright lights and noise, using gentle touch or massage, aromatherapy with calming scents like lavender, and coaching family members on how to speak softly and reassuringly without overstimulating the patient.9NWCommons. Non-Pharmacological Interventions for Terminal Restlessness in End-of-Life Care These interventions do not eliminate restlessness in most cases, but they can reduce its intensity and help families feel less helpless. For some patients, a familiar voice or a hand held quietly is enough to bring brief periods of calm.
When medications are needed, clinicians most often turn to antipsychotic drugs like haloperidol, which is widely used despite limited high-quality evidence for its effectiveness in this specific setting. For agitation that does not respond to antipsychotics alone, adding a benzodiazepine such as midazolam or lorazepam may achieve better control.10PubMed Central. Pharmacological Treatment for Terminal Agitation, Delirium and Anxiety in Frail Older Patients Reviews of the evidence have found that no single drug or drug class has been definitively shown to be the best option, and clinicians often try several approaches in sequence.11PubMed. Treatment of terminal restlessness: a review of the evidence
In cases where restlessness is truly refractory, meaning nothing is working and the person is clearly suffering, palliative sedation becomes an option. This involves using sedative medications to lower the person’s level of consciousness enough to relieve distress, sometimes continuously until death. Palliative sedation is reserved for the final days of life when all other measures have failed, and it is distinct from euthanasia in both intent and practice. The goal is to relieve suffering, not to hasten death.
What Families Actually Experience
For families, terminal restlessness is often the most distressing part of the dying process. Watching someone you love thrash, moan, or appear frightened when you cannot reach them through words or touch is psychologically devastating. The unpredictability adds to the burden: restlessness may calm for an hour and then return with greater intensity, making it impossible for caregivers to know when they can step away to rest or whether they need to stay at the bedside.
Research on families’ experiences emphasizes that clear communication from the care team makes a significant difference.2PubMed. The impact on the family of terminal restlessness and its management Families who understand ahead of time that restlessness is common and does not necessarily mean the person is in pain tend to cope better than those who are blindsided by it. Hospice professionals generally recommend that families be told several things early: that restlessness may happen, that it does not always mean the person is suffering (the agitation can be neurological rather than experiential), that it usually means death is relatively near, and that the care team has tools to manage it even if they cannot eliminate it entirely.
One of the hardest things for families to accept is that sedating medications may reduce responsiveness along with the agitation. A person who was intermittently lucid between episodes of restlessness may become continuously unresponsive once medications are adjusted. For some families, losing those last moments of connection is a painful trade-off, even when the alternative is watching the person suffer. Honest conversations about these trade-offs ahead of time, ideally before the active dying phase, help families feel more prepared when decisions need to be made quickly.
Terminal Restlessness in Children
Terminal restlessness is not limited to adults. In children with life-limiting illnesses, anxiety and restlessness appear to follow a similar pattern of escalation near the end of life. One study of children and adolescents receiving palliative care found that about 16% experienced anxiety and restlessness at the beginning of their palliative care, but that number climbed to about 57% during the terminal phase, defined as the last two weeks of life.12PubMed Central. Clinical Characteristics of the End-of-Life Phase in Children with Life-Limiting Diseases: Retrospective Study from a Single Center for Pediatric Palliative Care The jump is dramatic, and it underscores that the phenomenon is not simply an adult one.
Pediatric cases bring additional complexity. Young children cannot describe what they are feeling, so clinicians and parents must rely entirely on behavioral cues to distinguish between pain, fear, delirium, and restlessness. The emotional toll on parents is immense, and pediatric palliative care teams tend to involve child-life specialists and psychologists alongside physicians to support the family as a unit.
How Clinicians Assess Severity
One of the persistent challenges in managing terminal restlessness is measuring it consistently. Two people can watch the same patient and disagree about whether the agitation is mild or severe, which makes treatment decisions harder. Researchers have developed observer-rated scales for this purpose. The Agitation Distress Scale, for example, was validated for use with terminally ill cancer patients and showed strong reliability, meaning that different clinicians using it tended to arrive at similar scores.13PubMed. Communication Capacity Scale and Agitation Distress Scale to measure the severity of delirium in terminally ill cancer patients: a validation study More recently, a four-point rating scale for terminal agitation was developed using structured expert consensus, giving clinicians a simpler bedside tool.14PubMed. Terminal agitation: the Delphi method for a symptom severity measurement tool
These tools matter because they help standardize care. Without them, one nurse might describe a patient as “mildly restless” while another calls the same behavior “severely agitated,” leading to very different medication decisions. The tools also help in research, making it possible to compare treatments across studies. But in day-to-day bedside care, especially in home hospice settings, formal scales are used less often than clinical judgment. The care team watches for escalation, responds to what they see, and adjusts.
When Restlessness Does Not Mean the End Is Imminent
One common misconception is that terminal restlessness always signals death within hours. While it is true that restlessness tends to intensify close to death, the presence of agitation alone does not guarantee an imminent timeline. The study on delirium reversibility found that delirium was “not necessarily a harbinger of imminent death,” particularly when the delirium had a treatable cause.5PubMed. Reversibility of delirium in terminally ill patients and predictors of mortality Some patients developed delirium weeks before dying, had it resolve with treatment, and then experienced it again closer to death.
The factors that best predicted how long a person with delirium would survive were the severity of the delirium itself, the person’s age, and the degree of organ failure.5PubMed. Reversibility of delirium in terminally ill patients and predictors of mortality Restlessness that appears alongside other signs of active dying, such as changes in breathing patterns, mottled skin, and prolonged unconsciousness, is a more reliable indicator that death is very close than restlessness that appears in isolation.
For families keeping vigil, this means that the onset of restlessness is a reason to call the hospice team and ask what they are seeing in the full clinical picture. It is not, by itself, a countdown clock. Some families have been told “it will be hours” based on restlessness alone, only to watch their loved one linger for days. Others have assumed there was still time, only to have death come quickly. Prognostication at the end of life remains genuinely difficult even for experienced clinicians, and restlessness is only one piece of a larger puzzle that includes breathing changes, circulation changes, and level of consciousness.
The Evidence Is Thinner Than You Might Expect
Given how common terminal restlessness is, the research base is surprisingly sparse. Most of what clinicians know about managing it comes from clinical experience, case series, and expert consensus rather than large randomized trials. The reasons are obvious: conducting controlled studies on actively dying people raises profound ethical and practical barriers. Patients cannot consent in the usual way, the population is inherently unstable, and withholding a potentially helpful treatment for a control group is hard to justify when someone is suffering in their final days.
The result is that many of the medications used to treat terminal restlessness are supported by clinical tradition and expert opinion more than by rigorous evidence. Haloperidol is the most commonly recommended first-line drug, yet high-quality data on its effectiveness specifically for terminal agitation is lacking.10PubMed Central. Pharmacological Treatment for Terminal Agitation, Delirium and Anxiety in Frail Older Patients Benzodiazepines, phenothiazines, and combinations of drugs are all used in practice, and reviews have concluded that there is not enough evidence to declare any single approach superior.11PubMed. Treatment of terminal restlessness: a review of the evidence Clinicians treat terminal restlessness because they have to, because the alternative is watching people suffer, but they are doing so with a smaller evidence base than families might assume.